Mitchell Ryan McAlpine

Mitchell McAlpine practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Mitchell McAlpine's NPI, 1548795016, was assigned on April 21, 2017. Mitchell McAlpine holds Idaho license M14736.

Mitchell McAlpine's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Mitchell McAlpine's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Mitchell McAlpine is also affiliated with Northwest Specialty Hospital. The medical group on file is Kootenai Health. Dmand AI also links Mitchell McAlpine to 3 more home health agencies, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account. Mitchell McAlpine's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Mitchell McAlpine practices, 8 sites in all. Vendor and product names are available with a free account.

Family medicine is Mitchell McAlpine's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Mitchell McAlpine is licensed in Idaho.

CMS data shows 1,317 Medicare services from Mitchell McAlpine across 9 procedure codes in 2024, for 367 Medicare patients. Medicare paid $80,307 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 367 Medicare patients who saw Mitchell McAlpine in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mitchell McAlpine's median patient age at 74, with 41% women.

In 2024, Mitchell McAlpine wrote 7,771 Medicare Part D claims for 599 patients. 87% of them were for generic drugs. CMS names the drug for 7,082 of them, across 119 drugs with 11 or more claims each, at $551,886 in total drug cost. In 2023, CMS named 6,028 claims across 113 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Mitchell McAlpine for performance year 2024, reported through an alternative payment model (APM). Mitchell McAlpine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 14 general payments to Mitchell McAlpine from 10 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $66.